GLP-1 coverage in Missouri
Documented Medicaid fee-for-service status and insurance-mandate activity — not a decision for your member ID.
Sources last checked October 29, 2026
Spot an error? Report a correction
Medicaid (obesity / weight-loss)
KFF, "Medicaid Coverage of and Spending on GLP-1s", January 2026
This is the KFF January 2026 fee-for-service survey row for Missouri. Managed-care plans in the same state can differ. GLP-1s prescribed for type 2 diabetes are covered by every state Medicaid program regardless of this row.
MO HealthNet covers Zepbound and Foundayo for weight-related indications with prior authorization, but not Wegovy for weight loss.
Adults 18 or older qualify for Zepbound or Foundayo with a BMI of 30 or higher, or a BMI of 27 or higher with at least one documented weight-related comorbid condition. Adolescents 12 to 17 qualify at a BMI at or above the 95th percentile for age and sex.
Source: MO HealthNet Prior Authorization Form 2575-053, GLP-1 Receptor Agonists for All Indications, 2026-04
The form states: "Wegovy for the reduction of excess body weight or maintenance of weight reduction long term is not covered by MO HealthNet." Wegovy is covered for reducing major cardiovascular events (heart attack, stroke or symptomatic peripheral artery disease) and for noncirrhotic MASH with F2 or F3 fibrosis.
Source: MO HealthNet Prior Authorization Form 2575-053, GLP-1 Receptor Agonists for All Indications, 2026-04
Initial approval for Wegovy is for four weeks only, and titration continues until maintenance dosing is reached.
Source: MO HealthNet Prior Authorization Form 2575-053, GLP-1 Receptor Agonists for All Indications, 2026-04
Stateline reports that Missouri is among the states covering GLP-1s for obesity in 2026.
Source: Stateline (States Newsroom), as republished by The Lund Report, 2026-04-30
For drug-specific questions the form lists (800) 392-8030.
Source: MO HealthNet Prior Authorization Form 2575-053, GLP-1 Receptor Agonists for All Indications, 2026-04
Diabetes
The same form covers GLP-1s for type 2 diabetes. For diabetes requests it asks about a metformin trial and about trials of preferred agents before non-preferred ones. We have not summarized the full diabetes criteria here.
Source: MO HealthNet Prior Authorization Form 2575-053, GLP-1 Receptor Agonists for All Indications, 2026-04
State insurance-mandate activity
No mandate activity found in our current tracking for Missouri. That is not a denial — in most cases your employer plan matters more than a state statute. Full list: state laws.
What to do with this
Medicaid survey rows and mandate bills are not a prior-authorization approval. Call the number on your ID card and ask whether the drug is covered for your diagnosis.
Full 5-step checklist →Related: All state pages · Medicaid by state · State laws · Cash-pay options